Paris, France

Etienne Baulieu

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Etienne Baulieu: Innovator in Substance Use Disorder Treatments

Introduction

Etienne Baulieu is a prominent inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of substance use disorders and treatment-resistant depression. With a total of 2 patents, Baulieu's work is recognized for its innovative approach to addressing critical health issues.

Latest Patents

Baulieu's latest patents include groundbreaking inventions aimed at improving treatment options. One of his notable patents is focused on non-bioconvertible C-substituted pregnenolone derivatives for use in the treatment of substance use disorders. This invention relates to the use of these derivatives, which have no significant affinity for hormonal receptors or receptors of the central nervous system, specifically targeting alcohol use disorder. Another significant patent involves methods for treating treatment-resistant depression (TRD). This invention comprises the administration of compounds that are blocked in C-position and cannot metabolize in vivo into pregnenolone derivatives, ensuring they do not have significant affinity for steroid hormonal receptors or classical main receptors of neurotransmitters in the central nervous system.

Career Highlights

Throughout his career, Baulieu has been dedicated to advancing medical science through his innovative research. His work has not only contributed to the understanding of substance use disorders but has also paved the way for new treatment methodologies that can significantly improve patient outcomes.

Collaborations

Baulieu has collaborated with esteemed colleagues in his field, including Isabelle Villey and George F Koob. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

Etienne Baulieu's contributions to the field of medical research, particularly in the treatment of substance use disorders and treatment-resistant depression, highlight his role as a leading inventor. His innovative patents reflect a commitment to improving health outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…